Listar Biologie des maladies cardiovasculaires (BMC) - UMR 1034 por autor "OLLIVIER, Julien"
Mostrando ítems 1-4 de 4
-
Intérêt du lien ville-hôpital lors de la dispensation en rétrocession de traitements innovants : exemple du Sacubitril/Valsartan.
OLLIVIER, Julien; DE COUCY, Antoine; MEGNE-WABO, Michèle ...(Le Pharmacien Hospitalier et Clinicien. vol. 2, n° 52, pp. 367–376, 2017)Article de revue -
Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance?
OLLIVIER, Julien; CARRIÉ, Cédric; D’HOUDAIN, Nicolas ...(Antimicrobial Agents and Chemotherapy. vol. 63, n° 3, pp. e02134–18, 2019-01)Article de revueAcceso reservado -
Implementation of infliximab standardized doses after pharmacokinetic modelization in a cohort of patients with Crohn's disease.
POULLENOT, Florian; OLLIVIER, Julien; RIVIÈRE, Pauline ...(Digestive and Liver Disease. vol. 52, n° 4, pp. 408-413, 2020-01-01)Article de revueLibre acceso -
Higher than standard dosing regimen are needed to achieve optimal antibiotic exposure in critically ill patients with augmented renal clearance receiving piperacillin-tazobactam administered by continuous infusion
CARRIÉ, Cédric; LEGERON, Rachel; PETIT, Laurent ...(Journal of Critical Care. vol. 48, pp. 66–71, 2018)Article de revue